Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Apoptosis induced by neoadjuvant chemotherapy in breast cancer

2006; Elsevier BV; Volume: 38; Issue: 1 Linguagem: Inglês

10.1080/00313020500465315

1465-3931

Daniel Guimarães Tiezzi, Jurandyr Moreira de Andrade, Francisco José Cândido dos Reis, Heitor Ricardo Cosiski Marana, Alfredo Ribeiro‐Silva, Marcelo Guimarães Tiezzi, Antônio Plácido Pereira,

HER2/EGFR in Cancer Research

Summary Aim To evaluate the relationship between apoptosis induced by chemotherapy and clinical response in breast cancer. Methods Apoptosis index (AI), mutant p53 and Bcl-2 protein expression were evaluated in 44 breast tumour samples from patients submitted to neoadjuvant chemotherapy. Objective response (OR) to primary chemotherapy was observed in 37 patients (84%) and no response (NR) in seven. AI was measured by the rate of apoptotic cells identified using morphological criteria. p53 and Bcl-2 protein expression were evaluated using an immunoperoxidase staining technique. Results The median AI change observed between prechemotherapy AI and post-chemotherapy AI was 0.84 in the OR group and 0.01 in the NR group, (rho=0.4; p =0.006). There was no change in Bcl-2 protein expression following chemotherapy. In the OR group, p53 protein expression was positive in 41.6% of patients before and in 22.2% after chemotherapy (difference = 16.6%; p =0.03). No change was detected in the NR group. Conclusion A positive correlation was found between the increase in AI and clinical response to neoadjuvant chemotherapy in locally advanced breast cancer.